Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis. (Q51818139)
Jump to navigation
Jump to search
scientific article published on 16 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis. |
scientific article published on 16 February 2009 |
Statements
1 reference
Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis. (English)
1 reference
Y H Choi
1 reference
J H Ahn
1 reference
S-B Kim
1 reference
K-H Jung
1 reference
G-Y Gong
1 reference
M-J Kim
1 reference
B-H Son
1 reference
S-H Ahn
1 reference
W K Kim
1 reference
16 February 2009
1 reference
1 reference
20
1 reference
1337-1343
1 reference
8
1 reference
Identifiers
1 reference
1 reference